L. Dussourd d'Hinterland

Bacterial ribosomal immunostimulants prime alveolar macrophages in vivo to produce interleukin 1 in vitro.

B. Klein, J. Pujol, P. Godard, 1991, Chest.

Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans

J. Bousquet, F. Michel, G. Normier, 1978, Infection and immunity.

Role of the polysaccharide and of the lipopolysaccharide in the immunoprotective capacity of Klebsiella pneumoniae ribosomes.

R. Fontanges, H. Wigzell, G. Normier, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

NK-cell stimulating properties of a membrane proteoglycane from non-capsulated Klebsiella pneumoniae biotype a.

U. Ramstedt, H. Wigzell, G. Normier, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis.

G. Normier, J. Bohbot, F. Catalan, 1989, Vaccine.

Polyclonal activation of murine B cells by a membrane proteoglycan of Klebsiella pneumoniae.

J. Revillard, G. Normier, A. D. de Fraissinette, 1987, Clinical and experimental immunology.

Ribosomal vaccines: preparation of subcellular fractions.

G. Normier, L. Dussourd d'Hinterland, J. Durand, 1980, Arzneimittel-Forschung.

Ribosomal vaccines: immunological study.

L. Dussourd d'Hinterland, A. Pinel, G. Rey, 1980, Arzneimittel-Forschung.

Ribosomes as carriers for antigenic determinants of the surface of micro-organisms.

H. Binz, H. Wigzell, G. Normier, 1992, Developments in biological standardization.

Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.

F. Michel, L. Dussourd d'Hinterland, A. Pinel, 1980, Arzneimittel-Forschung.